Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


The RMM study aimed to examine the ability of an established telehealth mood monitoring system (True Colours) to evaluate the impact on mood of initiating an injectable therapy in individuals with type 2 diabetes.


Pilot proof-of-concept non-interventional questionnaire study seeking to record possible mood changes in people with type 2 diabetes when first starting an injectable diabetes therapy


The study showed that an online self-management system could be used to monitor mood remotely in people with type 2 diabetes and could provide additional metrics to help guide diabetes management. The results are currently being submitted for publication.

Chief investigator

Rury Holman


University of Oxford


Diabetes Trials Unit, University of Oxford

Reference number